CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,723,159 | -15.9% | 521,896 | -0.1% | 0.00% | – |
Q2 2023 | $5,619,098 | -2.3% | 522,221 | -7.1% | 0.00% | – |
Q1 2023 | $5,751,449 | -50.8% | 562,214 | -49.3% | 0.00% | – |
Q4 2022 | $11,696,806 | +81.9% | 1,108,702 | +121.1% | 0.00% | – |
Q3 2022 | $6,429,000 | +5.7% | 501,516 | +5.7% | 0.00% | – |
Q2 2022 | $6,082,000 | -46.3% | 474,428 | -56.1% | 0.00% | -100.0% |
Q1 2022 | $11,324,000 | -37.6% | 1,081,537 | -8.0% | 0.00% | 0.0% |
Q4 2021 | $18,136,000 | +121.4% | 1,175,363 | +223.8% | 0.00% | – |
Q3 2021 | $8,192,000 | +39.6% | 362,959 | +59.3% | 0.00% | – |
Q2 2021 | $5,867,000 | -27.7% | 227,843 | +17.0% | 0.00% | – |
Q1 2021 | $8,118,000 | – | 194,815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
Birchview Capital, LP | 45,114 | $578,000 | 0.42% |